Stroke Survivors Who Experience Depression May Face Triple the Risk of Early Death
One study has found that those who are depressed after suffering a stroke may be three times more likely to die early and four times more likely to die from stroke than those who have not experienced stroke or depression. Click here to read more.
Blood Pressure Drugs May Reduce Dementia Risk
Patients taking blood pressure drugs called beta blockers may be less likely to experience changes in the brain that can be signs of Alzheimer’s disease and other types of dementia. Click here
for more.
Mayo Clinic: When It Comes to Spine Surgery, the July Effect is a Myth
The “July Effect” — the notion that July is the most dangerous time to be a patient because of new, inexperienced residents at hospitals — is a myth, at least when it comes to spine surgery, according to a new study from Mayo Clinic researchers. Research results show that there is no spike in in-hospital deaths or complications after surgery in July compared to other months. Click here to read more.
Get a Head Start on Attending the 82nd AANS Annual Scientific Meeting in San Francisco
Get the latest news and information on the AANS 2014 Annual Scientific meeting, and be one of the first to secure your housing for next year's event in San Francisco, April 5-9, 2014. To learn more, please click here.
NeuroPoint Alliance, N²QOD Profiled in Becker’s Spine Review
National Neurosurgery Quality and Outcomes Database (N²QOD) Director Anthony Asher, MD, FAANS; and Vice-director Matthew McGirt, MD, recently discussed the N²QOD database and NeuroPoint Alliance in a Q&A interview with Becker’s Spine Review. To read their thoughts on the growth and future of this dynamic neurosurgical registry and program, please click here.
Get the Latest Neurosurgical News From AANS' Twitter Platforms
Follow the world of neurosurgery by engaging with AANS' various Twitter feeds. You can get AANS news though Twitter via @AANSNeuro, research updates and other daily neurosurgical news from AANS Neurosurgeon at @AANSNeurosurg, and real-time legislative content and advocacy news on @neurosurgery.
Study: Personalized Drugs for Pediatric Brain Tumors Could Be On the Way
A new study from pediatric researchers offers insight to how gene-sequencing data could customize treatments based on specific mutations of a child’s brain tumor. After discovering major difference in how a gene mutates, researchers may be moving closer to personalizing drugs for cancer-stricken children. For more information, click here to read the full story.
Researchers Find Separating Tumors, Followed by Types of Stereotactic Radiosurgery Is Safe, Effective in Controlling Spinal Metastases
A new study from researchers has found that tumor "separation surgery" — where a spinal tumor is removed from the spine, followed by stereotactic radiosurgery to deliver radiation to the remaining metastatic tumor — is safe and effective in controlling spinal metastases, regardless of the radiosensitivity of the particular tumor type that has invaded the spine. To read more about this study, please click here.
Mayo Clinic in Arizona the Latest Clinic to Offer New Treatment Approach For Glioblastoma
A treatment that disrupts the growth of recurrent glioblastoma brain tumors through the use of a noninvasive device that provides continuous electrical pulses targeted toward tumor sites is now available at Mayo Clinic in Arizona. This treatment is available in the U.S. at centers whose staff members have been certified to use the NovoTTF-100A system. To find out more, please click here.
Scientists: Cancer-Causing Cells Are “Squishier” than Benign Cells
Researchers at the Methodist Hospital in Houston have found that a cell’s flexibility may indicate its likelihood to cause tumors. A new device is helping scientists identify cancer-causing cells, determine the success of treatment and assess the likelihood of metastasis. Click here to read more.